Cover Page
Cover Page - shares | 6 Months Ended | |
Jun. 30, 2023 | Jul. 20, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-38441 | |
Entity Registrant Name | ChampionX Corp | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 82-3066826 | |
Entity Address, Address Line One | 2445 Technology Forest Blvd, | |
Entity Address, Address Line Two | Building 4, 12th Floor | |
Entity Address, City or Town | The Woodlands, | |
Entity Address, State or Province | TX | |
Entity Address, Postal Zip Code | 77381 | |
City Area Code | (281) | |
Local Phone Number | 403-5772 | |
Security 12b Title | Common stock, $0.01 par value | |
Trading Symbol | CHX | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 196,581,903 | |
Entity Central Index Key | 0001723089 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue: | ||||
Lease and other revenue | $ 24,539 | $ 23,176 | $ 46,618 | $ 42,074 |
Total revenue | 926,600 | 932,572 | 1,874,947 | 1,798,532 |
Cost of goods and services | 644,394 | 720,684 | 1,309,386 | 1,379,034 |
Gross profit | 282,206 | 211,888 | 565,561 | 419,498 |
Costs and expenses: | ||||
Selling, general and administrative expense | 162,484 | 141,351 | 323,300 | 291,711 |
Loss on disposal group | 0 | 22,924 | 12,965 | 22,924 |
Interest expense, net | 14,544 | 10,765 | 27,010 | 22,128 |
Other expense (income), net | (3,104) | 9,357 | 2,191 | 10,677 |
Income before income taxes | 108,282 | 27,491 | 200,095 | 72,058 |
Provision for (benefit from) income taxes | 11,656 | (1,405) | 40,325 | 4,989 |
Net income | 96,626 | 28,896 | 159,770 | 67,069 |
Net income attributable to noncontrolling interest | 829 | 1,554 | 441 | 3,025 |
Net income attributable to ChampionX | $ 95,797 | $ 27,342 | $ 159,329 | $ 64,044 |
Earnings per share attributable to ChampionX: | ||||
Basic (in dollars per share) | $ 0.49 | $ 0.13 | $ 0.81 | $ 0.32 |
Diluted (in dollars per share) | $ 0.48 | $ 0.13 | $ 0.79 | $ 0.31 |
Weighted-average shares outstanding: | ||||
Basic (in shares) | 197,034 | 203,322 | 197,657 | 203,200 |
Diluted (in shares) | 200,735 | 208,714 | 201,694 | 208,863 |
Product revenue | ||||
Revenue: | ||||
Revenue | $ 813,416 | $ 807,553 | $ 1,646,439 | $ 1,558,221 |
Service revenue | ||||
Revenue: | ||||
Revenue | $ 88,645 | $ 101,843 | $ 181,890 | $ 198,237 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 96,626 | $ 28,896 | $ 159,770 | $ 67,069 |
Other comprehensive income (loss), net of tax: | ||||
Foreign currency translation adjustments | 9,020 | 21,169 | (1,656) | 19,604 |
Cash flow hedges | 231 | (3,403) | (4,458) | (4,702) |
Defined pension and other post-retirement benefits adjustments, net | (102) | 70 | (49) | 139 |
Other comprehensive income (loss) | 9,149 | 17,836 | (6,163) | 15,041 |
Comprehensive income | 105,775 | 46,732 | 153,607 | 82,110 |
Less: Comprehensive income attributable to noncontrolling interest | 829 | 1,554 | 441 | 3,025 |
Comprehensive income attributable to ChampionX | $ 104,946 | $ 45,178 | $ 153,166 | $ 79,085 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Current Assets: | ||
Cash and cash equivalents | $ 263,088 | $ 250,187 |
Receivables, net | 522,106 | 601,061 |
Inventories, net | 599,040 | 542,543 |
Assets held for sale | 13,165 | 29,334 |
Prepaid expenses and other current assets | 87,432 | 75,456 |
Total current assets | 1,484,831 | 1,498,581 |
Property, plant, and equipment, net of accumulated depreciation of $743,426 in 2023 and $693,226 in 2022 | 757,841 | 734,810 |
Goodwill | 669,067 | 679,488 |
Intangible assets, net | 270,599 | 305,010 |
Operating lease right-of-use assets | 84,476 | 92,928 |
Other non-current assets | 63,024 | 76,666 |
Total assets | 3,329,838 | 3,387,483 |
Current Liabilities: | ||
Current portion of long-term debt | 6,250 | 6,250 |
Accounts payable | 550,827 | 469,566 |
Accrued compensation and employee benefits | 85,521 | 102,750 |
Current portion of operating lease liabilities | 26,641 | 28,838 |
Accrued distributor fees | 19,297 | 102,034 |
Liabilities held for sale | 0 | 7,186 |
Accrued expenses and other current liabilities | 125,919 | 142,352 |
Total current liabilities | 814,455 | 858,976 |
Long-term debt | 595,165 | 621,702 |
Deferred income taxes | 72,399 | 94,235 |
Operating lease liabilities | 52,528 | 59,686 |
Other long-term liabilities | 82,969 | 75,669 |
Total liabilities | 1,617,516 | 1,710,268 |
Stockholders’ equity: | ||
Common stock (2.5 billion shares authorized, $0.01 par value) 196.3 million shares and 198.5 million shares issued and outstanding in 2023 and 2022, respectively | 1,963 | 1,985 |
Capital in excess of par value of common stock | 2,220,909 | 2,249,698 |
Accumulated deficit | (457,148) | (527,603) |
Accumulated other comprehensive loss | (35,693) | (29,530) |
ChampionX stockholders’ equity | 1,730,031 | 1,694,550 |
Noncontrolling interest | (17,709) | (17,335) |
Total equity | 1,712,322 | 1,677,215 |
Total liabilities and equity | $ 3,329,838 | $ 3,387,483 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Accumulated depreciation on property, plant and equipment | $ 743,426 | $ 693,226 |
Common stock, shares authorized (in shares) | 2,500,000,000 | 2,500,000,000 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares issued (in shares) | 196,300,000 | 198,500,000 |
Common stock, shares outstanding (in shares) | 196,300,000 | 198,500,000 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands | Total | Common Stock | Capital in Excess of Par Value | Accum. Deficit | Accum. Other Comp. Loss | Non-controlling Interest |
Beginning balance (in shares) at Dec. 31, 2021 | 202,866,000 | |||||
Beginning balance at Dec. 31, 2021 | $ 1,754,307 | $ 2,029 | $ 2,315,399 | $ (525,158) | $ (21,625) | $ (16,338) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 38,173 | 36,702 | 1,471 | |||
Other comprehensive income (loss) | (2,795) | (2,795) | ||||
Stock-based compensation (in shares) | 290,000 | |||||
Stock-based compensation | 4,728 | $ 3 | 4,725 | |||
Stock options exercised (in shares) | 189,000 | |||||
Stock options exercised | 1,055 | $ 1 | 1,054 | |||
Taxes withheld on issuance of stock-based awards | (2,639) | (2,639) | ||||
Dividends declared to common stockholders | (15,465) | (15,465) | ||||
Cumulative translation adjustments | 208 | 208 | ||||
Ending balance (in shares) at Mar. 31, 2022 | 203,345,000 | |||||
Ending balance at Mar. 31, 2022 | 1,777,572 | $ 2,033 | 2,318,539 | (503,921) | (24,420) | (14,659) |
Beginning balance (in shares) at Dec. 31, 2021 | 202,866,000 | |||||
Beginning balance at Dec. 31, 2021 | 1,754,307 | $ 2,029 | 2,315,399 | (525,158) | (21,625) | (16,338) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 67,069 | |||||
Other comprehensive income (loss) | 15,041 | |||||
Ending balance (in shares) at Jun. 30, 2022 | 202,931,000 | |||||
Ending balance at Jun. 30, 2022 | 1,792,855 | $ 2,029 | 2,315,965 | (503,089) | (6,584) | (15,466) |
Beginning balance (in shares) at Mar. 31, 2022 | 203,345,000 | |||||
Beginning balance at Mar. 31, 2022 | 1,777,572 | $ 2,033 | 2,318,539 | (503,921) | (24,420) | (14,659) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 28,896 | 27,342 | 1,554 | |||
Other comprehensive income (loss) | 17,836 | 17,836 | ||||
Stock-based compensation (in shares) | 64,000 | |||||
Stock-based compensation | 5,071 | $ 1 | 5,070 | |||
Stock options exercised (in shares) | 312,000 | |||||
Stock options exercised | 2,090 | $ 3 | 2,087 | |||
Taxes withheld on issuance of stock-based awards | (739) | (739) | ||||
Dividends declared to common stockholders | (15,494) | (15,494) | ||||
Repurchase and cancellation of common stock (in shares) | (790,000) | |||||
Repurchase and cancellation of common stock | (20,016) | $ (8) | (8,992) | (11,016) | ||
Distributions to noncontrolling interest | (2,369) | (2,369) | ||||
Cumulative translation adjustments | 8 | 8 | ||||
Ending balance (in shares) at Jun. 30, 2022 | 202,931,000 | |||||
Ending balance at Jun. 30, 2022 | $ 1,792,855 | $ 2,029 | 2,315,965 | (503,089) | (6,584) | (15,466) |
Beginning balance (in shares) at Dec. 31, 2022 | 198,500,000 | 198,466,000 | ||||
Beginning balance at Dec. 31, 2022 | $ 1,677,215 | $ 1,985 | 2,249,698 | (527,603) | (29,530) | (17,335) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 63,144 | 63,532 | (388) | |||
Other comprehensive income (loss) | (15,312) | (15,312) | ||||
Stock-based compensation (in shares) | 327,000 | |||||
Stock-based compensation | 5,234 | $ 3 | 5,231 | |||
Stock options exercised (in shares) | 481,000 | |||||
Stock options exercised | 3,014 | $ 5 | 3,009 | |||
Taxes withheld on issuance of stock-based awards | (5,100) | (5,100) | ||||
Dividends declared to common stockholders | (16,784) | (16,784) | ||||
Repurchase and cancellation of common stock (in shares) | (1,302,000) | |||||
Repurchase and cancellation of common stock | (40,427) | $ (13) | (14,811) | (25,603) | ||
Distributions to noncontrolling interest | (823) | (823) | ||||
Cumulative translation adjustments | 8 | 8 | ||||
Ending balance (in shares) at Mar. 31, 2023 | 197,972,000 | |||||
Ending balance at Mar. 31, 2023 | $ 1,670,169 | $ 1,980 | 2,238,027 | (506,458) | (44,842) | (18,538) |
Beginning balance (in shares) at Dec. 31, 2022 | 198,500,000 | 198,466,000 | ||||
Beginning balance at Dec. 31, 2022 | $ 1,677,215 | $ 1,985 | 2,249,698 | (527,603) | (29,530) | (17,335) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 159,770 | |||||
Other comprehensive income (loss) | $ (6,163) | |||||
Repurchase and cancellation of common stock (in shares) | (3,185,979) | |||||
Ending balance (in shares) at Jun. 30, 2023 | 196,300,000 | 196,296,000 | ||||
Ending balance at Jun. 30, 2023 | $ 1,712,322 | $ 1,963 | 2,220,909 | (457,148) | (35,693) | (17,709) |
Beginning balance (in shares) at Mar. 31, 2023 | 197,972,000 | |||||
Beginning balance at Mar. 31, 2023 | 1,670,169 | $ 1,980 | 2,238,027 | (506,458) | (44,842) | (18,538) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 96,626 | 95,797 | 829 | |||
Other comprehensive income (loss) | 9,149 | 9,149 | ||||
Stock-based compensation (in shares) | 180,000 | |||||
Stock-based compensation | 6,341 | $ 2 | 6,339 | |||
Stock options exercised (in shares) | 27,000 | |||||
Stock options exercised | 24 | $ 0 | 24 | |||
Taxes withheld on issuance of stock-based awards | (2,039) | (2,039) | ||||
Dividends declared to common stockholders | $ (16,758) | (16,758) | ||||
Repurchase and cancellation of common stock (in shares) | (1,883,480) | (1,883,000) | ||||
Repurchase and cancellation of common stock | $ (51,190) | $ (19) | (21,442) | (29,729) | ||
Ending balance (in shares) at Jun. 30, 2023 | 196,300,000 | 196,296,000 | ||||
Ending balance at Jun. 30, 2023 | $ 1,712,322 | $ 1,963 | $ 2,220,909 | $ (457,148) | $ (35,693) | $ (17,709) |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) - $ / shares | 3 Months Ended | ||||
May 11, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2022 | Mar. 31, 2022 | |
Statement of Stockholders' Equity [Abstract] | |||||
Dividends declared to common shareholders (in dollars per share) | $ 0.085 | $ 0.085 | $ 0.085 | $ 0.075 | $ 0.075 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Cash flows from operating activities: | ||
Net income | $ 159,770 | $ 67,069 |
Adjustments to reconcile net income to net cash flows from operating activities: | ||
Depreciation and amortization | 115,387 | 117,229 |
Loss on disposal group | 12,965 | 22,924 |
Stock-based compensation | 11,575 | 9,799 |
Provision for inventory obsolescence and write-downs | 12,344 | 6,926 |
Loss on debt extinguishment | 0 | 4,043 |
Deferred income taxes | (22,187) | (34,386) |
Gain on disposal of fixed assets | (1,070) | (6,284) |
Amortization of deferred loan costs and accretion of discount | 2,029 | 1,766 |
Other | 3,185 | 805 |
Changes in operating assets and liabilities (net of effects of foreign exchange): | ||
Receivables | 83,589 | (42,456) |
Inventories | (70,040) | (81,935) |
Leased assets | (22,125) | (13,949) |
Other assets | 3,135 | 16,133 |
Accounts payable | 40,632 | 21,507 |
Other liabilities | (120,901) | (58,076) |
Net cash flows provided by operating activities | 208,288 | 31,115 |
Cash flows from investing activities: | ||
Capital expenditures | (57,277) | (53,555) |
Proceeds from sale of fixed assets | 7,109 | 14,946 |
Acquisitions, net of cash acquired | 0 | (3,198) |
Net cash used for investing activities | (50,168) | (41,807) |
Cash flows from financing activities: | ||
Proceeds from long-term debt | 15,500 | 844,838 |
Repayment of long-term debt | (43,633) | (869,987) |
Payment of debt issue costs | 0 | (8,008) |
Repurchases of common stock | (91,617) | (20,016) |
Dividends paid | (31,591) | (15,465) |
Payments related to taxes withheld on stock-based compensation | (7,139) | (3,378) |
Proceeds from exercise of stock options | 3,038 | 3,145 |
Payment of finance lease obligations | (4,376) | (3,123) |
Distributions to noncontrolling interest | (823) | (2,369) |
Proceeds expected to be remitted under the Accounts Receivable Facility | 15,400 | 0 |
Net cash used for financing activities | (145,241) | (74,363) |
Effect of exchange rate changes on cash and cash equivalents | 22 | 659 |
Net increase (decrease) in cash and cash equivalents | 12,901 | (84,396) |
Cash and cash equivalents at beginning of period | 250,187 | 255,178 |
Cash and cash equivalents at end of period | $ 263,088 | $ 170,782 |
BASIS OF PRESENTATION AND SUMMA
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 6 Months Ended |
Jun. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of the Business ChampionX Corporation is a global leader in chemistry solutions, artificial lift systems, and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently, and sustainably around the world. Our expertise, innovative products, and digital technologies provide enhanced oil and gas production, transportation, and real-time emissions monitoring throughout the lifecycle of a well. Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with its subsidiaries where the context requires. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2023. Significant Accounting Policies Please refer to “Note 1 – Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 for the discussion of our significant accounting policies. New Accounting Standards Issued In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations,” which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The adoption of this ASU did not have a material effect on our consolidated financial statements, other than the newly required disclosures. See Note 15—Supply Chain Finance for information on our supplier finance programs. |
SEGMENT INFORMATION
SEGMENT INFORMATION | 6 Months Ended |
Jun. 30, 2023 | |
Segment Reporting [Abstract] | |
SEGMENT INFORMATION | SEGMENT INFORMATION Our reporting segments are: • Production Chemical Technologies—provides oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues. • Production & Automation Technologies—designs, manufactures, markets and services a full range of artificial lift equipment, end-to-end digital automation solutions, as well as other production equipment and asset monitoring technologies. Production & Automation Technologies’ products are sold under a collection of brands including Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline and Windrock. • Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings for use in oil and gas drill bits under the US Synthetic brand. • Reservoir Chemical Technologies—manufactures specialty products that support well stimulation, construction (including drilling and cementing) and remediation needs in the oil and natural gas industry. We refer to our Production Chemical Technologies segment and our Reservoir Chemical Technologies segment collectively as our Chemical Technologies business. Although Reservoir Chemical Technologies is not required to be disclosed separately as a reportable segment based on materiality, management believes the additional information may contribute to a better understanding of the business. Other business activities that do not meet the criteria of an operating segment have been combined into Corporate and other. Corporate and other includes (i) corporate and overhead expenses, and (ii) revenue and costs for activities that are not operating segments. Segment revenue and segment operating profit Three Months Ended June 30, Six Months Ended June 30, (in thousands) 2023 2022 2023 2022 Segment revenue: Production Chemical Technologies $ 574,302 $ 552,411 $ 1,165,986 $ 1,067,383 Production & Automation Technologies 254,156 242,399 505,704 462,748 Drilling Technologies 57,324 57,858 114,031 114,717 Reservoir Chemical Technologies 23,853 44,114 49,659 84,014 Corporate and other (1) 16,965 35,790 39,567 69,670 Total revenue $ 926,600 $ 932,572 $ 1,874,947 $ 1,798,532 Segment operating profit (loss): Production Chemical Technologies $ 87,163 $ 25,606 $ 153,477 $ 56,869 Production & Automation Technologies 33,208 23,650 68,000 48,360 Drilling Technologies 12,660 15,043 24,547 30,263 Reservoir Chemical Technologies 2,186 (8,147) 4,173 (11,616) Total segment operating profit 135,217 56,152 250,197 123,876 Corporate and other (1) 12,391 17,896 23,092 29,690 Interest expense, net 14,544 10,765 27,010 22,128 Income before income taxes $ 108,282 $ 27,491 $ 200,095 $ 72,058 _______________________ |
REVENUE
REVENUE | 6 Months Ended |
Jun. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
REVENUE | REVENUE Our revenue is generated primarily from product sales. Service revenue is generated from providing services to our customers. These services include installation, repair and maintenance, laboratory and logistics services, chemical management services, troubleshooting, reporting, water treatment services, technical advisory assistance, emissions detection and monitoring, and other field services. Lease revenue is derived from rental income of leased production equipment. As our costs are shared across the various revenue categories, cost of goods sold is not tracked separately and is not discretely identifiable. In certain geographical areas, the Company utilizes joint ventures and independent third-party distributors and sales agents to sell and market products and services. Amounts payable to independent third-party distributors and sales agents may fluctuate based on sales and timing of distributor fee payments. For services rendered by such independent third-party distributors and sales agents, the Company records the consideration received on a net basis within product revenue in our condensed consolidated statements of income. Additionally, amounts owed to distributors and sales agents are reported within accrued distributor fees within our consolidated balance sheets. Revenue disaggregated by geography was as follows: Three Months Ended June 30, 2023 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 236,917 $ 197,655 $ 44,233 $ 11,677 $ 7,014 $ 497,496 Latin America 116,083 5,457 — 3,044 752 125,336 Middle East & Africa 81,776 14,756 2,967 7,123 (53) 106,569 Canada 72,403 15,648 2,922 540 7 91,520 Europe 53,415 4,980 6,544 775 2,494 68,208 Asia-Pacific 8,572 3,527 658 692 6,751 20,200 Australia 5,136 12,133 — 2 — 17,271 Other — — — — — — Total revenue $ 574,302 $ 254,156 $ 57,324 $ 23,853 $ 16,965 $ 926,600 Three Months Ended June 30, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 205,457 $ 187,982 $ 45,848 $ 31,038 $ 20,039 $ 490,364 Latin America 124,540 6,358 — 3,221 905 135,024 Middle East & Africa 76,028 19,062 1,220 5,561 287 102,158 Canada 72,581 17,484 3,477 633 37 94,212 Europe 45,889 3,384 5,156 968 3,297 58,694 Asia-Pacific 9,518 784 2,142 909 11,225 24,578 Australia 4,960 7,308 15 91 — 12,374 Other 13,438 37 — 1,693 — 15,168 Total revenue $ 552,411 $ 242,399 $ 57,858 $ 44,114 $ 35,790 $ 932,572 Six Months Ended June 30, 2023 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 478,678 $ 390,196 $ 87,193 $ 24,250 $ 20,604 $ 1,000,921 Latin America 240,554 10,145 — 7,012 1,719 259,430 Middle East & Africa 158,763 30,177 5,448 13,860 (438) 207,810 Canada 146,567 36,185 6,689 958 18 190,417 Europe 103,218 9,939 12,704 1,143 5,125 132,129 Asia-Pacific 17,791 5,605 1,995 1,871 12,539 39,801 Australia 11,085 23,457 — 2 — 34,544 Other 9,330 — 2 563 — 9,895 Total revenue $ 1,165,986 $ 505,704 $ 114,031 $ 49,659 $ 39,567 $ 1,874,947 Six Months Ended June 30, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 396,363 $ 355,784 $ 92,667 $ 56,259 $ 41,893 $ 942,966 Latin America 224,145 11,361 — 6,811 1,630 243,947 Middle East & Africa 150,072 35,773 2,909 13,282 601 202,637 Canada 148,380 36,936 6,418 1,111 63 192,908 Europe 94,910 5,729 8,866 1,871 6,768 118,144 Asia-Pacific 18,001 2,455 3,817 1,954 18,715 44,942 Australia 10,803 14,583 15 199 — 25,600 Other 24,709 127 25 2,527 — 27,388 Total revenue $ 1,067,383 $ 462,748 $ 114,717 $ 84,014 $ 69,670 $ 1,798,532 ______________________ (1) Revenues associated with sales under the Cross Supply and Product Transfer Agreement with Ecolab are included within Corporate and other. Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user. Contract Balances The beginning and ending contract asset and contract liability balances from contracts with customers were as follows: (in thousands) June 30, 2023 December 31, 2022 Contract assets $ — $ — Contract liabilities - current $ 20,549 $ 14,113 |
INTANGIBLE ASSETS AND GOODWILL
INTANGIBLE ASSETS AND GOODWILL | 6 Months Ended |
Jun. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
INTANGIBLE ASSETS AND GOODWILL | INTANGIBLE ASSETS AND GOODWILL Intangible Assets The components of our definite- and indefinite-lived intangible assets were as follows: June 30, 2023 December 31, 2022 (in thousands) Gross Accumulated Net Gross Accumulated Net Definite-lived Customer relationships $ 583,522 $ 423,001 $ 160,521 $ 582,466 $ 407,212 $ 175,254 Unpatented technologies 142,760 65,713 77,047 142,760 56,264 86,496 Favorable supply agreements 57,000 57,000 — 57,000 49,056 7,944 Trademarks 59,862 37,865 21,997 59,856 36,048 23,808 Patents 38,346 32,112 6,234 38,175 31,481 6,694 Other 525 525 — 1,892 1,878 14 882,015 616,216 265,799 882,149 581,939 300,210 Indefinite-lived Trademarks 3,600 — 3,600 3,600 — 3,600 In-process research and development 1,200 — 1,200 1,200 — 1,200 4,800 — 4,800 4,800 — 4,800 Total $ 886,815 $ 616,216 $ 270,599 $ 886,949 $ 581,939 $ 305,010 Goodwill The carrying amount of goodwill, including changes therein, by reportable segment is below: (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total December 31, 2022 $ 367,084 $ 211,268 $ 101,136 $ — $ 679,488 Foreign currency translation (10,554) 133 — — (10,421) June 30, 2023 $ 356,530 $ 211,401 $ 101,136 $ — $ 669,067 Goodwill is not subject to amortization but is tested for impairment on an annual basis or more frequently if impairment indicators arise. |
DEBT
DEBT | 6 Months Ended |
Jun. 30, 2023 | |
Debt Disclosure [Abstract] | |
DEBT | DEBT Long-term debt consisted of the following: (in thousands) June 30, 2023 December 31, 2022 2022 Revolving Credit Facility $ — $ 25,000 2022 Term Loan Facility 620,304 623,438 Total 620,304 648,438 Net unamortized discounts and issuance costs (18,889) (20,486) Total long-term debt 601,415 627,952 Current portion of long-term debt (1) (6,250) (6,250) Long-term debt, less current portion $ 595,165 $ 621,702 _______________________ (1) Includes the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of June 30, 2023. On June 7, 2022, we entered into a restated credit agreement, which provides for (i) a $625.0 million seven-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700.0 million, of which $100.0 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility,” and, together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135.0 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022. As of June 30, 2023, we had no outstanding balance on the 2022 Revolving Credit Facility. The 2022 Term Loan Facility matures June 7, 2029 and the 2022 Revolving Credit Facility matures June 7, 2027. The 2022 Term Loan Facility is subject to mandatory amortization payments of 1% per annum of the initial commitment paid quarterly, which began on December 30, 2022. The Senior Secured Credit Facility contains customary representations and warranties, covenants, and events of default for loan facilities of this type. We were in compliance with all covenants as of June 30, 2023. At the Company’s election, outstanding borrowings under the Senior Secured Credit Facility will accrue interest at a per annum rate of (i) an adjusted SOFR rate plus the applicable spread or (ii) a base rate plus the applicable spread. On June 29, 2022, the Company executed a five-year amortizing floating-to-fixed interest rate swap to hedge our exposure to increases in variable interest rates on the 2022 Term Loan Facility. This interest rate swap agreement is based on a $300.0 million notional amount for the first three years, reducing to $150.0 million for years four and five. See Note 12—Derivatives and Hedging Transactions for additional information on interest rate swaps. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 6 Months Ended |
Jun. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES The Company is subject to various claims and contingencies related to, among other things, workers’ compensation, general liability (including product liability), automobile claims, health care claims, environmental matters, and lawsuits. We record liabilities where a contingent loss is probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. In accordance with applicable GAAP, the Company discloses a contingent liability even if the liability is not probable or the amount is not estimable, or both, if there is a reasonable possibility that a material loss may have been incurred. Guarantees and Indemnifications We have provided indemnities in connection with sales of certain businesses and assets, including indemnities for environmental health and safety, tax, and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities. As of June 30, 2023 and December 31, 2022, we had $72.2 million and $82.4 million, respectively, of outstanding letters of credit, surety bonds and guarantees, which expire at various dates through 2039. These financial instruments are primarily maintained as security for insurance, warranty, and other performance obligations. Generally, we would only be liable for the amount of these letters of credit, surety bonds, and guarantees in the event of default in the performance of our obligations, the probability of which we believe is remote. Litigation and Environmental Matters The Company is party to various proceedings and claims incidental to its business, including matters arising under provisions relating to the protection of the environment. We review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. While many of these matters involve inherent uncertainty, we believe that the amount of the liability, if any, ultimately incurred with respect to these proceedings and claims will not have a material adverse effect on our consolidated financial position, results of operations or cash flows. Environmental Matters The Company is currently participating in environmental assessments and remediation at approximately 11 locations, the majority of which are in the United States (“U.S.”), and environmental liabilities have been accrued reflecting our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of June 30, 2023 and December 31, 2022, environmental liability accruals related to these locations were $6.0 million and $5.9 million, respectively. Prior to the commencement of our operations as an independent publicly traded company in 2018, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma. Initial remedial efforts were undertaken at the time of discovery of the contamination and we have since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality (“ODEQ”). As part of the ongoing long-term remediation process, we contracted an engineering and consulting firm to develop a range of possible additional remedial alternatives in order to accelerate the remediation process and associated cost estimates for the work. In October 2019, we received the firm’s preliminary remedial alternatives for consideration. We have submitted our long-term remediation plan and it was approved by ODEQ. We are now in discussion with ODEQ to finalize a consent order. Because we have not yet finalized the consent order for further remediation at the site and discussions with ODEQ remain ongoing, we cannot fully anticipate the timing, outcome or possible impact of such further remedial activities, financial or otherwise. As a result of the recommendations in the report, we accrued liabilities for these remediation efforts of approximately $2.0 million as of December 31, 2019. Liabilities could increase in the future at such time as we ultimately reach agreement with ODEQ on our remediation plan and such liabilities become probable and can be reasonably estimated; however, there have been no changes to our estimated liability as of June 30, 2023. Matters Related to Deepwater Horizon Incident Response On April 22, 2010, the deepwater drilling platform, the Deepwater Horizon, operated by a subsidiary of BP plc, sank in the Gulf of Mexico after an explosion and fire, resulting in a massive oil spill. Certain entities that are now subsidiaries of ChampionX as a result of the acquisition of the Chemical Technologies business in 2020 (collectively the “COREXIT Defendants”) supplied COREXIT™ 9500, an oil dispersant product listed on the U.S. EPA National Contingency Plan Product Schedule, which was used in the response to the spill. In connection with the provision of COREXIT™ 9500, the COREXIT Defendants were named in several lawsuits. Cases arising out of the Deepwater Horizon accident were administratively transferred and consolidated for pre-trial purposes under In Re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, Case No. 10-md-02179 in the United States District Court in the Eastern District of Louisiana (E.D. La.) (“MDL 2179”). Claims related to the response to the oil spill were consolidated in a master complaint captioned the “B3 Master Complaint.” In 2011, Transocean Deepwater Drilling, Inc. and its affiliates (the “Transocean Entities”) named the COREXIT Defendants and other unaffiliated companies as first party defendants (In re the Complaint and Petition of Triton Asset Leasing GmbH, et al, MDL No. 2179, Civil Action 10-2771). In April and May 2011, the Transocean Entities, Cameron International Corporation, Halliburton Energy Services, Inc., M-I L.L.C., Weatherford U.S., L.P. and Weatherford International, Inc. (collectively, the “Cross Claimants”) filed cross claims in MDL 2179 against the COREXIT Defendants and other unaffiliated cross defendants. In April and June 2011, in support of its defense of the claims against it, the COREXIT Defendants filed counterclaims against the Cross Claimants. On May 18, 2012, the COREXIT Defendants filed a motion for summary judgment as to the claims in the B3 Master Complaint. On November 28, 2012, the Court granted the COREXIT Defendants’ motion and dismissed with prejudice the claims in the B3 Master Complaint asserted against the COREXIT Defendants. There currently remains one “B3” case that asserted claims against the COREXIT Defendants and that remains pending against other defendants. Because the Court’s decision was not a “final judgment” for purposes of appeal with respect to those claims, under Federal Rule of Appellate Procedure 4(a), the plaintiff will have 30 days after entry of final judgment in the case to appeal the Court’s summary judgment decision. |
RESTRUCTURING EXPENSE
RESTRUCTURING EXPENSE | 6 Months Ended |
Jun. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
RESTRUCTURING EXPENSE | RESTRUCTURING EXPENSE We approved various restructuring plans related to the consolidation of product lines and associated facility closures and workforce reductions during prior periods, which we expect to be completed during 2023. We recognized charges of $4.0 million and $6.2 million during the three and six months ended June 30, 2023, respectively, consisting primarily of contract termination costs, inventory obsolescence, and employee severance and related benefits. During the three and six months ended June 30, 2022, we recorded restructuring expense of $6.6 million and $15.1 million, respectively. The following table presents the restructuring expense by segment as classified in our condensed consolidated statements of income. Three Months Ended Six Months Ended (in thousands) 2023 2022 2023 2022 Segment restructuring expense (income): Production Chemical Technologies $ 3,434 $ 336 $ 4,578 $ 11,972 Production & Automation Technologies — 125 785 (4,022) Drilling Technologies — — — — Reservoir Chemical Technologies 427 5,358 823 6,101 Corporate and other 99 801 4 1,053 Total $ 3,960 $ 6,620 $ 6,190 $ 15,104 Statements of Income classification: Cost of goods and services $ 1,013 $ 5,147 $ 2,544 $ 1,008 Selling, general and administrative expense 2,947 1,473 3,646 14,096 Total $ 3,960 $ 6,620 $ 6,190 $ 15,104 Our liability balance for restructuring expense at June 30, 2023 reflects contract termination costs, employee severance and related benefits initiated during the period. Additional programs may be initiated during the remainder of 2023 with related restructuring charges. The following table details our restructuring accrual activities during the six months ended June 30, 2023: (in thousands) Restructuring Accrual Balance December 31, 2022 $ 28,518 Restructuring charges 6,190 Asset sales and write-offs (669) Payments (16,984) Other, including foreign currency translation (2) June 30, 2023 $ 17,053 |
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY | 6 Months Ended |
Jun. 30, 2023 | |
Stockholders' Equity Note [Abstract] | |
STOCKHOLDERS' EQUITY | STOCKHOLDERS' EQUITY Dividends On February 16, 2023, the Company announced that our Board of Directors (“Board”) approved an increase of our regular quarterly cash dividend to $0.085 per share of the Company’s common stock. Our second quarter cash dividend of $0.085 per share was declared on May 11, 2023 and is payable on July 28, 2023 to shareholders of record on July 7, 2023. As a result, we recorded a dividend payable of $17.3 million on our condensed consolidated balance sheet as of June 30, 2023. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors. Repurchases |
EARNINGS PER SHARE
EARNINGS PER SHARE | 6 Months Ended |
Jun. 30, 2023 | |
Earnings Per Share [Abstract] | |
EARNINGS PER SHARE | EARNINGS PER SHARE A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows: Three Months Ended June 30, Six Months Ended June 30, (in thousands, except per share data) 2023 2022 2023 2022 Net income attributable to ChampionX $ 95,797 $ 27,342 $ 159,329 $ 64,044 Weighted-average number of shares outstanding 197,034 203,322 197,657 203,200 Dilutive effect of stock-based compensation 3,701 5,392 4,037 5,663 Total shares and dilutive securities 200,735 208,714 201,694 208,863 Earnings per share attributable to ChampionX: Basic $ 0.49 $ 0.13 $ 0.81 $ 0.32 Diluted $ 0.48 $ 0.13 $ 0.79 $ 0.31 For all periods presented, the computation of diluted earnings per share excludes awards with an anti-dilutive impact. For the three and six months ended June 30, 2023, the diluted shares include the dilutive impact of equity awards except for approximately 1.0 million and 0.8 million shares, respectively, that were excluded because their inclusion would be anti-dilutive. For the three and six months ended June 30, 2022, the diluted shares include the dilutive impact of equity awards except for approximately 0.4 million shares and 0.4 million shares, respectively, that were excluded because their inclusion would be anti-dilutive. |
ACQUISITIONS AND DIVESTITURES
ACQUISITIONS AND DIVESTITURES | 6 Months Ended |
Jun. 30, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
ACQUISITIONS AND DIVESTITURES | ACQUISITIONS AND DIVESTITURES Acquisitions On February 23, 2022, we acquired the assets of Leak Surveys, Inc., a leader in optical gas imaging technology that provides aerial and ground-based emissions leak detection to the oil and gas industry. These assets have been included in our Production & Automation Technologies segment. Under the terms of the agreement, we paid an initial amount of $3.2 million, net of cash acquired, with an additional $0.5 million which was paid on the first anniversary of the closing date. We may also be required to make future payments of up to an additional $2.5 million, contingent on the future performance of the business. As part of our purchase price allocation, we recorded goodwill of $6.3 million in the first quarter of 2022. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements. Divestitures Due to the deteriorating business conditions in Russia following the Ukraine invasion and the resultant sanctions imposed by the United States, European Union, and United Kingdom, we initiated a plan to dispose of our operations in Russia (the “CT Russia Business”), which is included in our Production Chemical Technologies segment. As a result, the CT Russia Business met the criteria to be classified as held for sale during the second quarter of 2022 and we measured the carrying value of the disposal group to the lower of its carrying value or fair value less costs to sell. We assess the fair value of the CT Russia Business (less any costs to sell) each reporting period that it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale. Due to the continued deterioration of the business environment, increasing trade regulations and sanctions and Russia’s imposition of an exit tax on divestments to facilitate exit from in-country operations, we assessed the fair value less cost to sell the business as of March 31, 2023 to be zero, resulting in a $13.0 million pre-tax impairment expense recorded during the three months ended March 31, 2023. There were no changes in the three month period ended June 30, 2023. |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels: Level 1 - Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2 - Inputs include observable inputs other than quoted prices in active markets. Level 3 - Inputs are unobservable inputs for which there is little or no market data available. The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows: Carrying Amount (in thousands) Measurement Level June 30, 2023 December 31, 2022 Assets Foreign currency forward contracts Level 2 $ 2,456 $ 7,066 Interest rate swaps Level 2 5,982 8,476 Total $ 8,438 $ 15,542 Liabilities Foreign currency forward contracts Level 2 $ 3,821 $ 4,209 Interest rate swaps Level 2 — — Total $ 3,821 $ 4,209 The carrying value of foreign currency forward contracts is at fair value, which is determined based on foreign currency exchange rates as of the balance sheet date and is classified within Level 2. For purposes of fair value disclosure above, derivative values are presented gross. See Note 12—Derivatives and Hedging Transactions for further discussion of gross versus net presentation of the Company’s derivatives. The carrying amounts of cash and cash equivalents, trade receivables, and accounts payable approximate their fair value due to their short-term nature. The fair value of the 2022 Term Loan Facility is based on Level 2 quoted market prices for the same or similar debt instruments. The fair value of the 2022 Revolving Credit Facility approximates carrying value due to the variable interest rates charged on the borrowings, which reprice frequently (Level 2). The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were: June 30, 2023 December 31, 2022 (in thousands) Carrying Amount Fair Value Carrying Amount Fair Value 2022 Revolving Credit Facility $ — $ — $ 25,000 $ 25,000 2022 Term Loan Facility $ 620,304 $ 620,304 $ 623,438 $ 610,969 |
DERIVATIVES AND HEDGING TRANSAC
DERIVATIVES AND HEDGING TRANSACTIONS | 6 Months Ended |
Jun. 30, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
DERIVATIVES AND HEDGING TRANSACTIONS | DERIVATIVES AND HEDGING TRANSACTIONS The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company also utilizes floating-to-fixed interest rate swap agreements as cash flow hedges on certain debt to mitigate interest rate risk. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. Derivative contracts are recorded as assets and liabilities on the balance sheet at fair value. We evaluated the interest rate swap hedge effectiveness and determined it to be perfectly effective. We evaluate foreign currency forward contracts hedge effectiveness at contract inception and thereafter on a quarterly basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Changes in fair value attributable to changes in spot exchange rates for derivative contracts that have been designated as cash flow hedges are recognized in accumulated other comprehensive income (loss) (“AOCI”) and reclassified into earnings in the same period the hedged transaction affects earnings and are presented in the same income statement line as the earnings effect of the hedged item. The Company accounts for the interest rate swap agreements as a cash flow hedge, thus the effective portion of gains and losses resulting from changes in fair value are recognized in AOCI and are amortized to interest expense over the term of the respective debt. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships. The Company is exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swaps. We monitor our exposure to credit risk by using major banks and financial institutions as counterparties and monitoring their financial condition and credit profile. The Company does not anticipate nonperformance by any of these counterparties, and therefore, recording a valuation allowance against the Company’s derivative balance is not considered necessary. Derivative Positions Summary Certain of the Company’s derivative transactions are subject to master netting arrangements that allow the Company to settle with the same counterparties. These arrangements generally do not call for collateral and as of the applicable dates presented in the following table, no cash collateral had been received or pledged related to the underlying derivatives. We have elected to present our derivative balances on a gross basis on the condensed consolidated balance sheet. The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet. Derivative Assets Derivative Liabilities (in thousands) June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 Prepaid expenses and other current assets $ 7,705 $ 11,911 $ — $ — Other non-current assets 733 3,631 — — Accrued expenses and other current liabilities — — 3,821 4,209 $ 8,438 $ 15,542 $ 3,821 $ 4,209 The following table summarizes the notional values of the Company’s outstanding derivatives: (in thousands) June 30, 2023 December 31, 2022 Notional value of foreign currency forward contracts and interest rate swaps $ 931,238 $ 965,973 Cash Flow Hedges The Company utilizes foreign currency forward contracts to hedge the effect of foreign currency exchange rate fluctuations on forecasted foreign currency transactions, primarily related to inventory purchases. These forward contracts are designated as cash flow hedges. The changes in fair value of these contracts attributable to changes in spot exchange rates are recorded in AOCI until the hedged items affect earnings, at which time the gain or loss is reclassified into the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged. The forward points are marked-to-market monthly and recognized in the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged. Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount. Any unrealized gain or loss at the time of settlement will be reclassified to interest expense, where we record the interest expense on the associated debt. Derivatives Not Designated as Hedging Instruments The Company also uses foreign currency forward contracts to offset its exposure to the change in value of certain foreign currency denominated assets and liabilities, primarily receivables and payables, which are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Therefore, changes in the value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities. Effect of Derivative Instruments on Income The loss of all derivative instruments recognized is summarized below: Three Months Ended Six Months Ended (in thousands) 2023 2022 2023 2022 Loss (gain) reclassified from AOCI to income on cash flow hedges: Cost of goods and services $ (966) $ (118) $ (1,923) $ (47) Interest expense (1,322) — (2,259) — Loss on derivatives not designated as hedging instruments: Other (income) expense, net 906 1,251 2,347 5,411 Total loss of derivative instruments $ (1,382) $ 1,133 $ (1,835) $ 5,364 |
INVENTORIES
INVENTORIES | 6 Months Ended |
Jun. 30, 2023 | |
Inventory, Net [Abstract] | |
INVENTORIES | INVENTORIES Inventories consisted of the following: (in thousands) June 30, 2023 December 31, 2022 Raw materials $ 157,451 $ 142,571 Work in progress 20,456 19,582 Finished goods 518,913 467,628 696,820 629,781 Inventory reserve (34,010) (24,702) LIFO adjustments (1) (63,770) (62,536) Inventories, net $ 599,040 $ 542,543 _______________________ (1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value. |
ACCOUNTS RECEIVABLE FACILITY
ACCOUNTS RECEIVABLE FACILITY | 6 Months Ended |
Jun. 30, 2023 | |
Receivables [Abstract] | |
ACCOUNTS RECEIVABLE FACILITY | ACCOUNTS RECEIVABLE FACILITY On June 28, 2022, we entered into an uncommitted accounts receivable purchase agreement (the “Accounts Receivable Facility”) with JPMorgan Chase Bank, N.A. as the purchaser. Transfers under the Accounts Receivable Facility are accounted for as sales of receivables, resulting in the receivables being derecognized from our condensed consolidated balance sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign or transfer (including as a participation interest) any of its rights under the purchased receivables to another bank or financial institution. The amount available for sale under the Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. A maximum of $160.0 million in receivables may be sold and remain unpaid under the Accounts Receivable Facility at any time. Accounts receivable sold were $359.3 million for the six months ended June 30, 2023. The accounts receivable sold that remained outstanding as of June 30, 2023 was $112.6 million. During this period, cash receipts from the purchaser at the time of the sale were classified as operating activities in our condensed consolidated statement of cash flows. The difference between the carrying amount of the accounts receivable sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense), net in our condensed consolidated statements of income. The loss on sale of accounts receivable was $1.8 million and $3.4 million for the three and six months ended June 30, 2023, respectively. |
SUPPLY CHAIN FINANCE
SUPPLY CHAIN FINANCE | 6 Months Ended |
Jun. 30, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
SUPPLY CHAIN FINANCE | SUPPLY CHAIN FINANCEWe use a supply chain finance program in connection with the purchase of goods, which allows our suppliers to work directly with a third party to provide financing by purchasing their receivables earlier in the payment cycle. We maintain the same contractually agreed upon invoice terms prior to each supplier entering into the program. As of June 30, 2023, we had approximately $50.0 million outstanding under the program, which is included in accounts payable on our condensed consolidated balance sheet. |
CASH FLOW INFORMATION
CASH FLOW INFORMATION | 6 Months Ended |
Jun. 30, 2023 | |
Supplemental Cash Flow Elements [Abstract] | |
CASH FLOW INFORMATION | CASH FLOW INFORMATION Leased Asset Program Our electrical submersible pumping leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our leased asset program. During the six months ended June 30, 2023 and 2022, we transferred $54.8 million and $34.7 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our leased asset program. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Pay vs Performance Disclosure | ||||
Net income attributable to ChampionX | $ 95,797 | $ 27,342 | $ 159,329 | $ 64,044 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
BASIS OF PRESENTATION AND SUM_2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 6 Months Ended |
Jun. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2023. |
New Accounting Standards Issued | New Accounting Standards Issued In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations,” which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The adoption of this ASU did not have a material effect on our consolidated financial statements, other than the newly required disclosures. See Note 15—Supply Chain Finance for information on our supplier finance programs. |
Fair Value Measurements | Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels: Level 1 - Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2 - Inputs include observable inputs other than quoted prices in active markets. Level 3 - Inputs are unobservable inputs for which there is little or no market data available. |
SEGMENT INFORMATION (Tables)
SEGMENT INFORMATION (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Segment Revenue and Operating Profit | Segment revenue and segment operating profit Three Months Ended June 30, Six Months Ended June 30, (in thousands) 2023 2022 2023 2022 Segment revenue: Production Chemical Technologies $ 574,302 $ 552,411 $ 1,165,986 $ 1,067,383 Production & Automation Technologies 254,156 242,399 505,704 462,748 Drilling Technologies 57,324 57,858 114,031 114,717 Reservoir Chemical Technologies 23,853 44,114 49,659 84,014 Corporate and other (1) 16,965 35,790 39,567 69,670 Total revenue $ 926,600 $ 932,572 $ 1,874,947 $ 1,798,532 Segment operating profit (loss): Production Chemical Technologies $ 87,163 $ 25,606 $ 153,477 $ 56,869 Production & Automation Technologies 33,208 23,650 68,000 48,360 Drilling Technologies 12,660 15,043 24,547 30,263 Reservoir Chemical Technologies 2,186 (8,147) 4,173 (11,616) Total segment operating profit 135,217 56,152 250,197 123,876 Corporate and other (1) 12,391 17,896 23,092 29,690 Interest expense, net 14,544 10,765 27,010 22,128 Income before income taxes $ 108,282 $ 27,491 $ 200,095 $ 72,058 _______________________ |
REVENUE (Tables)
REVENUE (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Revenue | Revenue disaggregated by geography was as follows: Three Months Ended June 30, 2023 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 236,917 $ 197,655 $ 44,233 $ 11,677 $ 7,014 $ 497,496 Latin America 116,083 5,457 — 3,044 752 125,336 Middle East & Africa 81,776 14,756 2,967 7,123 (53) 106,569 Canada 72,403 15,648 2,922 540 7 91,520 Europe 53,415 4,980 6,544 775 2,494 68,208 Asia-Pacific 8,572 3,527 658 692 6,751 20,200 Australia 5,136 12,133 — 2 — 17,271 Other — — — — — — Total revenue $ 574,302 $ 254,156 $ 57,324 $ 23,853 $ 16,965 $ 926,600 Three Months Ended June 30, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 205,457 $ 187,982 $ 45,848 $ 31,038 $ 20,039 $ 490,364 Latin America 124,540 6,358 — 3,221 905 135,024 Middle East & Africa 76,028 19,062 1,220 5,561 287 102,158 Canada 72,581 17,484 3,477 633 37 94,212 Europe 45,889 3,384 5,156 968 3,297 58,694 Asia-Pacific 9,518 784 2,142 909 11,225 24,578 Australia 4,960 7,308 15 91 — 12,374 Other 13,438 37 — 1,693 — 15,168 Total revenue $ 552,411 $ 242,399 $ 57,858 $ 44,114 $ 35,790 $ 932,572 Six Months Ended June 30, 2023 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 478,678 $ 390,196 $ 87,193 $ 24,250 $ 20,604 $ 1,000,921 Latin America 240,554 10,145 — 7,012 1,719 259,430 Middle East & Africa 158,763 30,177 5,448 13,860 (438) 207,810 Canada 146,567 36,185 6,689 958 18 190,417 Europe 103,218 9,939 12,704 1,143 5,125 132,129 Asia-Pacific 17,791 5,605 1,995 1,871 12,539 39,801 Australia 11,085 23,457 — 2 — 34,544 Other 9,330 — 2 563 — 9,895 Total revenue $ 1,165,986 $ 505,704 $ 114,031 $ 49,659 $ 39,567 $ 1,874,947 Six Months Ended June 30, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 396,363 $ 355,784 $ 92,667 $ 56,259 $ 41,893 $ 942,966 Latin America 224,145 11,361 — 6,811 1,630 243,947 Middle East & Africa 150,072 35,773 2,909 13,282 601 202,637 Canada 148,380 36,936 6,418 1,111 63 192,908 Europe 94,910 5,729 8,866 1,871 6,768 118,144 Asia-Pacific 18,001 2,455 3,817 1,954 18,715 44,942 Australia 10,803 14,583 15 199 — 25,600 Other 24,709 127 25 2,527 — 27,388 Total revenue $ 1,067,383 $ 462,748 $ 114,717 $ 84,014 $ 69,670 $ 1,798,532 ______________________ |
Schedule of Contract Balances | The beginning and ending contract asset and contract liability balances from contracts with customers were as follows: (in thousands) June 30, 2023 December 31, 2022 Contract assets $ — $ — Contract liabilities - current $ 20,549 $ 14,113 |
INTANGIBLE ASSETS AND GOODWILL
INTANGIBLE ASSETS AND GOODWILL (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Finite-Lived Intangible Assets | The components of our definite- and indefinite-lived intangible assets were as follows: June 30, 2023 December 31, 2022 (in thousands) Gross Accumulated Net Gross Accumulated Net Definite-lived Customer relationships $ 583,522 $ 423,001 $ 160,521 $ 582,466 $ 407,212 $ 175,254 Unpatented technologies 142,760 65,713 77,047 142,760 56,264 86,496 Favorable supply agreements 57,000 57,000 — 57,000 49,056 7,944 Trademarks 59,862 37,865 21,997 59,856 36,048 23,808 Patents 38,346 32,112 6,234 38,175 31,481 6,694 Other 525 525 — 1,892 1,878 14 882,015 616,216 265,799 882,149 581,939 300,210 Indefinite-lived Trademarks 3,600 — 3,600 3,600 — 3,600 In-process research and development 1,200 — 1,200 1,200 — 1,200 4,800 — 4,800 4,800 — 4,800 Total $ 886,815 $ 616,216 $ 270,599 $ 886,949 $ 581,939 $ 305,010 |
Schedule of Indefinite-Lived Intangible Assets | The components of our definite- and indefinite-lived intangible assets were as follows: June 30, 2023 December 31, 2022 (in thousands) Gross Accumulated Net Gross Accumulated Net Definite-lived Customer relationships $ 583,522 $ 423,001 $ 160,521 $ 582,466 $ 407,212 $ 175,254 Unpatented technologies 142,760 65,713 77,047 142,760 56,264 86,496 Favorable supply agreements 57,000 57,000 — 57,000 49,056 7,944 Trademarks 59,862 37,865 21,997 59,856 36,048 23,808 Patents 38,346 32,112 6,234 38,175 31,481 6,694 Other 525 525 — 1,892 1,878 14 882,015 616,216 265,799 882,149 581,939 300,210 Indefinite-lived Trademarks 3,600 — 3,600 3,600 — 3,600 In-process research and development 1,200 — 1,200 1,200 — 1,200 4,800 — 4,800 4,800 — 4,800 Total $ 886,815 $ 616,216 $ 270,599 $ 886,949 $ 581,939 $ 305,010 |
Schedule of Goodwill | The carrying amount of goodwill, including changes therein, by reportable segment is below: (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total December 31, 2022 $ 367,084 $ 211,268 $ 101,136 $ — $ 679,488 Foreign currency translation (10,554) 133 — — (10,421) June 30, 2023 $ 356,530 $ 211,401 $ 101,136 $ — $ 669,067 |
DEBT (Tables)
DEBT (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Long-Term Debt | Long-term debt consisted of the following: (in thousands) June 30, 2023 December 31, 2022 2022 Revolving Credit Facility $ — $ 25,000 2022 Term Loan Facility 620,304 623,438 Total 620,304 648,438 Net unamortized discounts and issuance costs (18,889) (20,486) Total long-term debt 601,415 627,952 Current portion of long-term debt (1) (6,250) (6,250) Long-term debt, less current portion $ 595,165 $ 621,702 _______________________ (1) Includes the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of June 30, 2023. |
RESTRUCTURING EXPENSE (Tables)
RESTRUCTURING EXPENSE (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Restructuring Charges | The following table presents the restructuring expense by segment as classified in our condensed consolidated statements of income. Three Months Ended Six Months Ended (in thousands) 2023 2022 2023 2022 Segment restructuring expense (income): Production Chemical Technologies $ 3,434 $ 336 $ 4,578 $ 11,972 Production & Automation Technologies — 125 785 (4,022) Drilling Technologies — — — — Reservoir Chemical Technologies 427 5,358 823 6,101 Corporate and other 99 801 4 1,053 Total $ 3,960 $ 6,620 $ 6,190 $ 15,104 Statements of Income classification: Cost of goods and services $ 1,013 $ 5,147 $ 2,544 $ 1,008 Selling, general and administrative expense 2,947 1,473 3,646 14,096 Total $ 3,960 $ 6,620 $ 6,190 $ 15,104 The following table details our restructuring accrual activities during the six months ended June 30, 2023: (in thousands) Restructuring Accrual Balance December 31, 2022 $ 28,518 Restructuring charges 6,190 Asset sales and write-offs (669) Payments (16,984) Other, including foreign currency translation (2) June 30, 2023 $ 17,053 |
EARNINGS PER SHARE (Tables)
EARNINGS PER SHARE (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share | A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows: Three Months Ended June 30, Six Months Ended June 30, (in thousands, except per share data) 2023 2022 2023 2022 Net income attributable to ChampionX $ 95,797 $ 27,342 $ 159,329 $ 64,044 Weighted-average number of shares outstanding 197,034 203,322 197,657 203,200 Dilutive effect of stock-based compensation 3,701 5,392 4,037 5,663 Total shares and dilutive securities 200,735 208,714 201,694 208,863 Earnings per share attributable to ChampionX: Basic $ 0.49 $ 0.13 $ 0.81 $ 0.32 Diluted $ 0.48 $ 0.13 $ 0.79 $ 0.31 |
FAIR VALUE MEASUREMENTS (Tables
FAIR VALUE MEASUREMENTS (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets and Liabilities Measured on Recurring Basis | The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows: Carrying Amount (in thousands) Measurement Level June 30, 2023 December 31, 2022 Assets Foreign currency forward contracts Level 2 $ 2,456 $ 7,066 Interest rate swaps Level 2 5,982 8,476 Total $ 8,438 $ 15,542 Liabilities Foreign currency forward contracts Level 2 $ 3,821 $ 4,209 Interest rate swaps Level 2 — — Total $ 3,821 $ 4,209 |
Schedule of Fair Value of Long-Term Debt | The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were: June 30, 2023 December 31, 2022 (in thousands) Carrying Amount Fair Value Carrying Amount Fair Value 2022 Revolving Credit Facility $ — $ — $ 25,000 $ 25,000 2022 Term Loan Facility $ 620,304 $ 620,304 $ 623,438 $ 610,969 |
DERIVATIVES AND HEDGING TRANS_2
DERIVATIVES AND HEDGING TRANSACTIONS (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Notional Values of Outstanding Derivatives | The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet. Derivative Assets Derivative Liabilities (in thousands) June 30, 2023 December 31, 2022 June 30, 2023 December 31, 2022 Prepaid expenses and other current assets $ 7,705 $ 11,911 $ — $ — Other non-current assets 733 3,631 — — Accrued expenses and other current liabilities — — 3,821 4,209 $ 8,438 $ 15,542 $ 3,821 $ 4,209 The following table summarizes the notional values of the Company’s outstanding derivatives: (in thousands) June 30, 2023 December 31, 2022 Notional value of foreign currency forward contracts and interest rate swaps $ 931,238 $ 965,973 |
Schedule of Derivative Instruments | The loss of all derivative instruments recognized is summarized below: Three Months Ended Six Months Ended (in thousands) 2023 2022 2023 2022 Loss (gain) reclassified from AOCI to income on cash flow hedges: Cost of goods and services $ (966) $ (118) $ (1,923) $ (47) Interest expense (1,322) — (2,259) — Loss on derivatives not designated as hedging instruments: Other (income) expense, net 906 1,251 2,347 5,411 Total loss of derivative instruments $ (1,382) $ 1,133 $ (1,835) $ 5,364 |
INVENTORIES (Tables)
INVENTORIES (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Inventory, Net [Abstract] | |
Components of Inventory | Inventories consisted of the following: (in thousands) June 30, 2023 December 31, 2022 Raw materials $ 157,451 $ 142,571 Work in progress 20,456 19,582 Finished goods 518,913 467,628 696,820 629,781 Inventory reserve (34,010) (24,702) LIFO adjustments (1) (63,770) (62,536) Inventories, net $ 599,040 $ 542,543 _______________________ (1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value. |
SEGMENT INFORMATION (Details)
SEGMENT INFORMATION (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Segment Reporting Information [Line Items] | ||||
Total revenue | $ 926,600 | $ 932,572 | $ 1,874,947 | $ 1,798,532 |
Income before income taxes | 108,282 | 27,491 | 200,095 | 72,058 |
Interest expense, net | 14,544 | 10,765 | 27,010 | 22,128 |
Operating Segments | ||||
Segment Reporting Information [Line Items] | ||||
Income before income taxes | 135,217 | 56,152 | 250,197 | 123,876 |
Operating Segments | Production Chemical Technologies | ||||
Segment Reporting Information [Line Items] | ||||
Total revenue | 574,302 | 552,411 | 1,165,986 | 1,067,383 |
Income before income taxes | 87,163 | 25,606 | 153,477 | 56,869 |
Operating Segments | Production & Automation Technologies | ||||
Segment Reporting Information [Line Items] | ||||
Total revenue | 254,156 | 242,399 | 505,704 | 462,748 |
Income before income taxes | 33,208 | 23,650 | 68,000 | 48,360 |
Operating Segments | Drilling Technologies | ||||
Segment Reporting Information [Line Items] | ||||
Total revenue | 57,324 | 57,858 | 114,031 | 114,717 |
Income before income taxes | 12,660 | 15,043 | 24,547 | 30,263 |
Operating Segments | Reservoir Chemical Technologies | ||||
Segment Reporting Information [Line Items] | ||||
Total revenue | 23,853 | 44,114 | 49,659 | 84,014 |
Income before income taxes | 2,186 | (8,147) | 4,173 | (11,616) |
Corporate and Other | ||||
Segment Reporting Information [Line Items] | ||||
Total revenue | 16,965 | 35,790 | 39,567 | 69,670 |
Income before income taxes | $ 12,391 | $ 17,896 | $ 23,092 | $ 29,690 |
REVENUE - Disaggregation of Rev
REVENUE - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 926,600 | $ 932,572 | $ 1,874,947 | $ 1,798,532 |
United States | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 497,496 | 490,364 | 1,000,921 | 942,966 |
Latin America | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 125,336 | 135,024 | 259,430 | 243,947 |
Middle East & Africa | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 106,569 | 102,158 | 207,810 | 202,637 |
Canada | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 91,520 | 94,212 | 190,417 | 192,908 |
Europe | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 68,208 | 58,694 | 132,129 | 118,144 |
Asia-Pacific | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 20,200 | 24,578 | 39,801 | 44,942 |
Australia | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 17,271 | 12,374 | 34,544 | 25,600 |
Other | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 0 | 15,168 | 9,895 | 27,388 |
Operating Segments | Production Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 574,302 | 552,411 | 1,165,986 | 1,067,383 |
Operating Segments | Production & Automation Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 254,156 | 242,399 | 505,704 | 462,748 |
Operating Segments | Drilling Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 57,324 | 57,858 | 114,031 | 114,717 |
Operating Segments | Reservoir Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 23,853 | 44,114 | 49,659 | 84,014 |
Operating Segments | United States | Production Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 236,917 | 205,457 | 478,678 | 396,363 |
Operating Segments | United States | Production & Automation Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 197,655 | 187,982 | 390,196 | 355,784 |
Operating Segments | United States | Drilling Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 44,233 | 45,848 | 87,193 | 92,667 |
Operating Segments | United States | Reservoir Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 11,677 | 31,038 | 24,250 | 56,259 |
Operating Segments | Latin America | Production Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 116,083 | 124,540 | 240,554 | 224,145 |
Operating Segments | Latin America | Production & Automation Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 5,457 | 6,358 | 10,145 | 11,361 |
Operating Segments | Latin America | Drilling Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 0 | 0 | 0 | 0 |
Operating Segments | Latin America | Reservoir Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 3,044 | 3,221 | 7,012 | 6,811 |
Operating Segments | Middle East & Africa | Production Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 81,776 | 76,028 | 158,763 | 150,072 |
Operating Segments | Middle East & Africa | Production & Automation Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 14,756 | 19,062 | 30,177 | 35,773 |
Operating Segments | Middle East & Africa | Drilling Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 2,967 | 1,220 | 5,448 | 2,909 |
Operating Segments | Middle East & Africa | Reservoir Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 7,123 | 5,561 | 13,860 | 13,282 |
Operating Segments | Canada | Production Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 72,403 | 72,581 | 146,567 | 148,380 |
Operating Segments | Canada | Production & Automation Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 15,648 | 17,484 | 36,185 | 36,936 |
Operating Segments | Canada | Drilling Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 2,922 | 3,477 | 6,689 | 6,418 |
Operating Segments | Canada | Reservoir Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 540 | 633 | 958 | 1,111 |
Operating Segments | Europe | Production Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 53,415 | 45,889 | 103,218 | 94,910 |
Operating Segments | Europe | Production & Automation Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 4,980 | 3,384 | 9,939 | 5,729 |
Operating Segments | Europe | Drilling Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 6,544 | 5,156 | 12,704 | 8,866 |
Operating Segments | Europe | Reservoir Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 775 | 968 | 1,143 | 1,871 |
Operating Segments | Asia-Pacific | Production Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 8,572 | 9,518 | 17,791 | 18,001 |
Operating Segments | Asia-Pacific | Production & Automation Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 3,527 | 784 | 5,605 | 2,455 |
Operating Segments | Asia-Pacific | Drilling Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 658 | 2,142 | 1,995 | 3,817 |
Operating Segments | Asia-Pacific | Reservoir Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 692 | 909 | 1,871 | 1,954 |
Operating Segments | Australia | Production Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 5,136 | 4,960 | 11,085 | 10,803 |
Operating Segments | Australia | Production & Automation Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 12,133 | 7,308 | 23,457 | 14,583 |
Operating Segments | Australia | Drilling Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 0 | 15 | 0 | 15 |
Operating Segments | Australia | Reservoir Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 2 | 91 | 2 | 199 |
Operating Segments | Other | Production Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 0 | 13,438 | 9,330 | 24,709 |
Operating Segments | Other | Production & Automation Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 0 | 37 | 0 | 127 |
Operating Segments | Other | Drilling Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 0 | 0 | 2 | 25 |
Operating Segments | Other | Reservoir Chemical Technologies | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 0 | 1,693 | 563 | 2,527 |
Corporate and other | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 16,965 | 35,790 | 39,567 | 69,670 |
Corporate and other | United States | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 7,014 | 20,039 | 20,604 | 41,893 |
Corporate and other | Latin America | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 752 | 905 | 1,719 | 1,630 |
Corporate and other | Middle East & Africa | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | (53) | 287 | (438) | 601 |
Corporate and other | Canada | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 7 | 37 | 18 | 63 |
Corporate and other | Europe | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 2,494 | 3,297 | 5,125 | 6,768 |
Corporate and other | Asia-Pacific | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 6,751 | 11,225 | 12,539 | 18,715 |
Corporate and other | Australia | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 0 | 0 | 0 | 0 |
Corporate and other | Other | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 0 | $ 0 | $ 0 | $ 0 |
REVENUE - Contract Balances (De
REVENUE - Contract Balances (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Revenue from Contract with Customer [Abstract] | ||
Contract assets | $ 0 | $ 0 |
Contract liabilities - current | $ 20,549 | $ 14,113 |
INTANGIBLE ASSETS AND GOODWIL_2
INTANGIBLE ASSETS AND GOODWILL - Schedule of Intangibles (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 882,015 | $ 882,149 |
Accumulated Amortization | 616,216 | 581,939 |
Net Carrying Amount | 265,799 | 300,210 |
Indefinite-lived Intangible Assets [Line Items] | ||
Indefinite-lived intangible assets | 4,800 | 4,800 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Intangible assets, gross | 886,815 | 886,949 |
Accumulated Amortization | 616,216 | 581,939 |
Intangible assets, net | 270,599 | 305,010 |
Trademarks | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Indefinite-lived intangible assets | 3,600 | 3,600 |
In-process research and development | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Indefinite-lived intangible assets | 1,200 | 1,200 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 583,522 | 582,466 |
Accumulated Amortization | 423,001 | 407,212 |
Net Carrying Amount | 160,521 | 175,254 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Accumulated Amortization | 423,001 | 407,212 |
Unpatented technologies | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 142,760 | 142,760 |
Accumulated Amortization | 65,713 | 56,264 |
Net Carrying Amount | 77,047 | 86,496 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Accumulated Amortization | 65,713 | 56,264 |
Favorable supply agreements | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 57,000 | 57,000 |
Accumulated Amortization | 57,000 | 49,056 |
Net Carrying Amount | 0 | 7,944 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Accumulated Amortization | 57,000 | 49,056 |
Trademarks | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 59,862 | 59,856 |
Accumulated Amortization | 37,865 | 36,048 |
Net Carrying Amount | 21,997 | 23,808 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Accumulated Amortization | 37,865 | 36,048 |
Patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 38,346 | 38,175 |
Accumulated Amortization | 32,112 | 31,481 |
Net Carrying Amount | 6,234 | 6,694 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Accumulated Amortization | 32,112 | 31,481 |
Other | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 525 | 1,892 |
Accumulated Amortization | 525 | 1,878 |
Net Carrying Amount | 0 | 14 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Accumulated Amortization | $ 525 | $ 1,878 |
INTANGIBLE ASSETS AND GOODWIL_3
INTANGIBLE ASSETS AND GOODWILL - Schedule of Goodwill (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2023 USD ($) | |
Goodwill [Roll Forward] | |
Beginning balance | $ 679,488 |
Foreign currency translation | (10,421) |
Ending balance | 669,067 |
Production Chemical Technologies | |
Goodwill [Roll Forward] | |
Beginning balance | 367,084 |
Foreign currency translation | (10,554) |
Ending balance | 356,530 |
Production & Automation Technologies | |
Goodwill [Roll Forward] | |
Beginning balance | 211,268 |
Foreign currency translation | 133 |
Ending balance | 211,401 |
Drilling Technologies | |
Goodwill [Roll Forward] | |
Beginning balance | 101,136 |
Foreign currency translation | 0 |
Ending balance | 101,136 |
Reservoir Chemical Technologies | |
Goodwill [Roll Forward] | |
Beginning balance | 0 |
Foreign currency translation | 0 |
Ending balance | $ 0 |
DEBT - Long-term Debt (Details)
DEBT - Long-term Debt (Details) - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||
Total | $ 620,304,000 | $ 648,438,000 |
Net unamortized discounts and issuance costs | (18,889,000) | (20,486,000) |
Total long-term debt | 601,415,000 | 627,952,000 |
Current portion of long-term debt | (6,250,000) | (6,250,000) |
Long-term debt, less current portion | 595,165,000 | 621,702,000 |
2022 Term Loan Facility | Term Loan Facility | ||
Debt Instrument [Line Items] | ||
Total | 620,304,000 | 623,438,000 |
Revolving Credit Facility | 2022 Revolving Credit Facility | Credit Facility | ||
Debt Instrument [Line Items] | ||
Total | $ 0 | $ 25,000,000 |
DEBT - Narrative (Details)
DEBT - Narrative (Details) - USD ($) | Jun. 29, 2022 | Jun. 07, 2022 | Jun. 30, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||||
Carrying Amount | $ 620,304,000 | $ 648,438,000 | ||
Interest rate swaps | Designated as Hedging Instrument | ||||
Debt Instrument [Line Items] | ||||
Derivative instrument, term (in years) | 5 years | |||
Interest Rate Swap, First Three Years | Designated as Hedging Instrument | ||||
Debt Instrument [Line Items] | ||||
Notional value of foreign currency forward contracts and interest rate swaps | $ 300,000,000 | |||
Interest Rate Swap, Years Four And Five | Designated as Hedging Instrument | ||||
Debt Instrument [Line Items] | ||||
Notional value of foreign currency forward contracts and interest rate swaps | $ 150,000,000 | |||
2022 Term Loan Facility | Term Loan Facility | ||||
Debt Instrument [Line Items] | ||||
Principal amount of debt issued | $ 625,000,000 | |||
Debt instrument, term (in years) | 7 years | |||
Carrying Amount | 620,304,000 | 623,438,000 | ||
Mandatory amortization payment, percent per annum | 1% | |||
2022 Revolving Credit Facility | Credit Facility | Revolving Credit Facility | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, term (in years) | 5 years | |||
Maximum borrowing capacity | $ 700,000,000 | |||
Borrowings from lines of credit | 135,000,000 | |||
Carrying Amount | $ 0 | $ 25,000,000 | ||
2022 Revolving Credit Facility | Credit Facility | Letter of Credit | ||||
Debt Instrument [Line Items] | ||||
Maximum borrowing capacity | $ 100,000,000 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details) $ in Millions | 6 Months Ended | ||
Jun. 30, 2023 USD ($) case location | Dec. 31, 2022 USD ($) | Dec. 31, 2019 USD ($) | |
Commitments and Contingencies Disclosure [Abstract] | |||
Outstanding letters of credit, surety bonds and guarantees | $ 72.2 | $ 82.4 | |
Number of locations participating in assessments and remediation | location | 11 | ||
Accrued environmental liability | $ 6 | $ 5.9 | $ 2 |
Number of pending cases | case | 1 |
RESTRUCTURING EXPENSE - Narrati
RESTRUCTURING EXPENSE - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Restructuring and Related Activities [Abstract] | ||||
Restructuring expense | $ 3,960 | $ 6,620 | $ 6,190 | $ 15,104 |
RESTRUCTURING EXPENSE - Schedul
RESTRUCTURING EXPENSE - Schedule of Restructuring Charges (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring expense | $ 3,960 | $ 6,620 | $ 6,190 | $ 15,104 |
Cost of goods and services | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring expense | 1,013 | 5,147 | 2,544 | 1,008 |
Selling, general and administrative expense | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring expense | 2,947 | 1,473 | 3,646 | 14,096 |
Operating Segments | Production Chemical Technologies | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring expense | 3,434 | 336 | 4,578 | 11,972 |
Operating Segments | Production & Automation Technologies | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring expense | 0 | 125 | 785 | (4,022) |
Operating Segments | Drilling Technologies | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring expense | 0 | 0 | 0 | 0 |
Operating Segments | Reservoir Chemical Technologies | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring expense | 427 | 5,358 | 823 | 6,101 |
Corporate and other | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring expense | $ 99 | $ 801 | $ 4 | $ 1,053 |
RESTRUCTURING EXPENSE - Restruc
RESTRUCTURING EXPENSE - Restructuring Reserve Rollforward (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2023 USD ($) | |
Restructuring Accrual Balance | |
Beginning balance | $ 28,518 |
Restructuring charges | 6,190 |
Asset sales and write-offs | (669) |
Payments | (16,984) |
Other, including foreign currency translation | (2) |
Ending balance | $ 17,053 |
STOCKHOLDERS' EQUITY (Details)
STOCKHOLDERS' EQUITY (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||||||
May 11, 2023 | Feb. 16, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2022 | Mar. 31, 2022 | Jun. 30, 2023 | Oct. 24, 2022 | Mar. 07, 2022 | |
Stockholders' Equity Note [Abstract] | |||||||||
Approved quarterly cash dividend (in dollars per share) | $ 0.085 | ||||||||
Dividends declared to common shareholders (in dollars per share) | $ 0.085 | $ 0.085 | $ 0.085 | $ 0.075 | $ 0.075 | ||||
Dividends payable | $ 17,300,000 | $ 17,300,000 | |||||||
Authorized amount of stock repurchase | $ 750,000,000 | $ 250,000,000 | |||||||
Repurchase and cancellation of common stock (in shares) | 1,883,480 | 3,185,979 | |||||||
Value of repurchased common stock | $ 51,200,000 | $ 91,600,000 |
EARNINGS PER SHARE (Details)
EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Earnings Per Share [Abstract] | ||||
Net income attributable to ChampionX | $ 95,797 | $ 27,342 | $ 159,329 | $ 64,044 |
Weighted-average number of shares outstanding (in shares) | 197,034 | 203,322 | 197,657 | 203,200 |
Dilutive effect of stock-based compensation (in shares) | 3,701 | 5,392 | 4,037 | 5,663 |
Total shares and dilutive securities (in shares) | 200,735 | 208,714 | 201,694 | 208,863 |
Earnings per share attributable to ChampionX: | ||||
Basic (in dollars per share) | $ 0.49 | $ 0.13 | $ 0.81 | $ 0.32 |
Diluted (in dollars per share) | $ 0.48 | $ 0.13 | $ 0.79 | $ 0.31 |
Number of antidilutive securities excluded (in shares) | 1,000 | 400 | 800 | 400 |
ACQUISITIONS AND DIVESTITURES (
ACQUISITIONS AND DIVESTITURES (Details) - USD ($) | 3 Months Ended | |||||
Feb. 23, 2023 | Feb. 23, 2022 | Mar. 31, 2023 | Jun. 30, 2023 | Dec. 31, 2022 | Mar. 31, 2022 | |
Business Acquisition [Line Items] | ||||||
Goodwill | $ 669,067,000 | $ 679,488,000 | ||||
Disposal Group, Held-for-sale, Not Discontinued Operations | CT Russia Business | ||||||
Business Acquisition [Line Items] | ||||||
Recoverable value on divestiture | $ 0 | |||||
Pre-tax impairment expense | $ 13,000,000 | |||||
Leak Surveys, Inc. | ||||||
Business Acquisition [Line Items] | ||||||
Amount paid for acquisition | $ 500,000 | $ 3,200,000 | ||||
Future payments contingent upon performance | $ 2,500,000 | |||||
Goodwill | $ 6,300,000 |
FAIR VALUE MEASUREMENTS - Asset
FAIR VALUE MEASUREMENTS - Assets And Liabilities (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Assets | ||
Derivative assets | $ 8,438 | $ 15,542 |
Liabilities | ||
Derivative liabilities | 3,821 | 4,209 |
Level 2 | Fair Value, Recurring | ||
Assets | ||
Derivative assets | 8,438 | 15,542 |
Liabilities | ||
Derivative liabilities | 3,821 | 4,209 |
Foreign currency forward contracts | Level 2 | Fair Value, Recurring | ||
Assets | ||
Derivative assets | 2,456 | 7,066 |
Liabilities | ||
Derivative liabilities | 3,821 | 4,209 |
Interest rate swaps | Level 2 | Fair Value, Recurring | ||
Assets | ||
Derivative assets | 5,982 | 8,476 |
Liabilities | ||
Derivative liabilities | $ 0 | $ 0 |
FAIR VALUE MEASUREMENTS - Fair
FAIR VALUE MEASUREMENTS - Fair Value of Long-term Debt (Details) - Level 2 - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Carrying Amount | 2022 Revolving Credit Facility | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term debt | $ 0 | $ 25,000 |
Carrying Amount | 2022 Term Loan Facility | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term debt | 620,304 | 623,438 |
Fair Value | 2022 Revolving Credit Facility | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term debt | 0 | 25,000 |
Fair Value | 2022 Term Loan Facility | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Long-term debt | $ 620,304 | $ 610,969 |
DERIVATIVES AND HEDGING TRANS_3
DERIVATIVES AND HEDGING TRANSACTIONS - Schedule of Fair Value of Derivative Instruments (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Derivative Assets | ||
Derivative asset, current | $ 7,705 | $ 11,911 |
Derivative asset, noncurrent | 733 | 3,631 |
Derivative assets | $ 8,438 | $ 15,542 |
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] | Prepaid expenses and other current assets | Prepaid expenses and other current assets |
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other Assets, Noncurrent | Other Assets, Noncurrent |
Derivative Liabilities | ||
Derivative liability, current | $ 3,821 | $ 4,209 |
Derivative liabilities | $ 3,821 | $ 4,209 |
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] | Accrued expenses and other current liabilities | Accrued expenses and other current liabilities |
DERIVATIVES AND HEDGING TRANS_4
DERIVATIVES AND HEDGING TRANSACTIONS - Schedule of Derivative Instruments (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Foreign Exchange Forward Contracts and Interest Rate Swap | ||
Derivative [Line Items] | ||
Notional value of foreign currency forward contracts and interest rate swaps | $ 931,238 | $ 965,973 |
DERIVATIVES AND HEDGING TRANS_5
DERIVATIVES AND HEDGING TRANSACTIONS - Schedule of Gain (Loss) on Derivative Instruments (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||
Total loss of derivative instruments | $ (1,382) | $ 1,133 | $ (1,835) | $ 5,364 |
Cost of goods and services | Designated as Hedging Instrument | ||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||
Total loss of derivative instruments | (966) | (118) | (1,923) | (47) |
Interest expense | Designated as Hedging Instrument | ||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||
Total loss of derivative instruments | (1,322) | 0 | (2,259) | 0 |
Other (income) expense, net | Not Designated as Hedging Instrument | ||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||
Total loss of derivative instruments | $ 906 | $ 1,251 | $ 2,347 | $ 5,411 |
INVENTORIES (Details)
INVENTORIES (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Inventory, Net [Abstract] | ||
Raw materials | $ 157,451 | $ 142,571 |
Work in progress | 20,456 | 19,582 |
Finished goods | 518,913 | 467,628 |
Subtotal | 696,820 | 629,781 |
Inventory reserve | (34,010) | (24,702) |
LIFO adjustments | (63,770) | (62,536) |
Inventories, net | $ 599,040 | $ 542,543 |
ACCOUNTS RECEIVABLE FACILITY (D
ACCOUNTS RECEIVABLE FACILITY (Details) - Accounts receivable held for sale under Accounts Receivable Facility - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2023 | Jun. 28, 2022 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Maximum accounts receivable that can be sold | $ 160 | ||
Accounts receivable sold | $ 359.3 | ||
Accounts receivable outstanding | $ 112.6 | 112.6 | |
Loss on sale of trade receivable | $ 1.8 | $ 3.4 |
SUPPLY CHAIN FINANCE (Details)
SUPPLY CHAIN FINANCE (Details) $ in Millions | Jun. 30, 2023 USD ($) |
Investments, Debt and Equity Securities [Abstract] | |
Supply chain finance outstanding | $ 50 |
CASH FLOW INFORMATION (Details)
CASH FLOW INFORMATION (Details) - USD ($) $ in Millions | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Supplemental Cash Flow Elements [Abstract] | ||
Transfers from inventory | $ 54.8 | $ 34.7 |